HIV Maintenance Therapy With T-20 During HAART Interruption

NCT00013884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: T-20

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)